{"id":"https://openalex.org/W2786946485","doi":null,"title":"Comparative Effectiveness Research/Health Technology Assessment (HTA) Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models","display_name":"Comparative Effectiveness Research/Health Technology Assessment (HTA) Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2786946485","mag":"2786946485"},"language":"en","primary_location":{"id":"mag:2786946485","doi":null,"is_oa":false,"landing_page_url":"https://www.ispor.org/ValueInHealth/ShowValueInHealth.aspx?issue=82C0C0A6-00ED-4407-852D-630B0F6C5A09","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016531633","display_name":"Shannon F. Cope","orcid":"https://orcid.org/0000-0002-1721-9485","observed_orcids":["https://orcid.org/0000-0002-1721-9485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon Cope","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1721-9485","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013727360","display_name":"Jeroen Paul Jansen","orcid":"https://orcid.org/0000-0003-2686-9217","observed_orcids":["https://orcid.org/0000-0003-2686-9217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeroen P. Jansen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2686-9217","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111951182","display_name":"Peter Schmid","orcid":"https://orcid.org/0000-0001-9817-5228","observed_orcids":["https://orcid.org/0000-0001-9817-5228"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Schmid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8335000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8335000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.12880000472068787,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9679999947547913},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.7490000128746033},{"id":"https://openalex.org/keywords/second-line-endocrine-therapy","display_name":"second-line endocrine therapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9449999928474426},{"id":"https://openalex.org/keywords/parametric-survival-models","display_name":"parametric survival models","score":0.8970000147819519},{"id":"https://openalex.org/keywords/network-meta-analysis","display_name":"network meta-analysis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.8484992384910583},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6564709544181824},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6509451866149902},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5437596440315247},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5057976245880127},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.43477484583854675},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.37798500061035156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3717665374279022},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3570379912853241},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.353995680809021},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2805904150009155},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.23657825589179993}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2786946485","doi":null,"is_oa":false,"landing_page_url":"https://www.ispor.org/ValueInHealth/ShowValueInHealth.aspx?issue=82C0C0A6-00ED-4407-852D-630B0F6C5A09","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1505367831","https://openalex.org/W1569625389","https://openalex.org/W1839333839","https://openalex.org/W1909697168","https://openalex.org/W1934173384","https://openalex.org/W1967385770","https://openalex.org/W1979370923","https://openalex.org/W1982967337","https://openalex.org/W1995662976","https://openalex.org/W2003639965","https://openalex.org/W2056271161","https://openalex.org/W2057765075","https://openalex.org/W2058306712","https://openalex.org/W2059573268","https://openalex.org/W2084941037","https://openalex.org/W2099326967","https://openalex.org/W2113144077","https://openalex.org/W2114495058","https://openalex.org/W2124847703","https://openalex.org/W2125776201","https://openalex.org/W2133667885","https://openalex.org/W2135369095","https://openalex.org/W2139726760","https://openalex.org/W2140699272","https://openalex.org/W2142334766","https://openalex.org/W2142405101","https://openalex.org/W2171423946","https://openalex.org/W2202169216","https://openalex.org/W4230686738"],"related_works":["https://openalex.org/W2049265027","https://openalex.org/W2264348589","https://openalex.org/W2402249538","https://openalex.org/W2690569173","https://openalex.org/W1979196695","https://openalex.org/W2394805951","https://openalex.org/W2944341352","https://openalex.org/W2031580997","https://openalex.org/W7098717753","https://openalex.org/W2938485110"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-02-23T00:00:00"}